ArticleOncotarget2018

Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells.

Vojtech Novohradsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.